A new precision oncology paper was published in , Volume 16, on March 12, 2025, titled "Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation ...

PPH researchers apply cutting-edge AI and computational models to massive datasets to develop a deep understanding of the ...

QTScan is the next revolution in breast cancer imaging and screening. A new technology that focuses on being radiation-free, compression-free, and similar imaging quality to an MRI. It’s ...

When someone is traumatically injured, giving them blood products before they arrive at the hospital—such as at the scene or ...

“A new era in genetic testing has arrived,” said Carlos Bustamante, Ph.D., CEO & Co-Founder, Galatea Bio. “StrataRisk PRS empowers clinical genetic labs to deliver more informative reports to ...

Sara Robinson, senior associate healthcare architect at McMillan Pazdan Smith Architecture, and Jamie Feinour, vice president ...

OnKure's drug candidate pipeline is highlighted by OKI-219, a selective PI3K alpha H1047R inhibitor for the treatment of certain types of breast cancer that began clinical trials in February 2024.

Porter Logo (PRNewsfoto/Porter) Members are overwhelmed by fragmented vendor outreach. Porter simplifies this by being the ...

Pennington Biomedical Research Center's Dr. Yun Shen will lead a team to explore the use of AI for precision hypertension management in Type-2 diabetes care.

Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a multi-year ...

Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a multi-year agreement with all Danish healthcare regions.